Korro Bio, Inc. (KRRO) SEC Filings — 2025
12 SEC filings for Korro Bio, Inc. (KRRO) in 2025.
Filings
- Korro Bio, Inc. 8-K Filing — 8-K · Dec 18, 2025
- Korro Bio's Cash Dwindles Amidst Program Pivot and Novo Nordisk Pause — 10-Q · Nov 12, 2025
- Korro Bio Announces Board and Executive Changes — 8-K · Oct 8, 2025
- Korro Bio's Q2 Net Loss Widens to $28.3M Amid R&D Re-prioritization — 10-Q · Aug 12, 2025
- Korro Bio Files 8-K/A Amendment — 8-K/A · Jun 18, 2025
- Korro Bio Files 8-K on Shareholder Vote Matters — 8-K · Jun 11, 2025
- Korro Bio Files Q1 2025 10-Q — 10-Q · May 7, 2025
- Korro Bio DEF 14A: Executive Compensation Details — DEF 14A · Apr 29, 2025
- Korro Bio, Inc. Files 8-K: Leadership and Compensation Changes — 8-K · Mar 27, 2025
- Korro Bio, Inc. 10-K Filing — 10-K · Mar 18, 2025
- Korro Bio Appoints New Director, Officer Compensation Details — 8-K · Feb 11, 2025
- Korro Bio Files 8-K — 8-K · Jan 13, 2025